Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Nov 2010

van Helden P M W, Kaijen P H P, Mauser-Bunschoten E P, Fischer K, van den Berg H M, Voorberg J

Abstract excerpt

UNLABELLED: INTRODUCTION: Frequent administration of high dosages factor VIII (FVIII), so-called immune tolerance induction (ITI), provides an efficient strategy to eradicate inhibitory antibodies in patients with haemophilia A. At present, our knowledge on the characteristics of inhibitory antibodies in patients undergoing ITI is limited. AIM: In this study we characterized the domain specificity of FVIII...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibody Specificity
Share to Blood Coagulation Factor Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Factor VIII

Share to Hemophilia A

Share to Immune Tolerance

Share to Mutation

Source

Identifiers

PMID: 20491952
DOI: 10.1111/j.1365-2516.2010.02272.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A.PMID 20491952Read ↗

Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A.Semantic proximity Read ↗

T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide.Semantic proximity Read ↗

Immune tolerance induction in patients with hemophilia A.Semantic proximity Read ↗

Inhibitors: resolving diagnostic and therapeutic dilemmas.Semantic proximity Read ↗

Development of inhibitors in hemophilia A: An illustrated reviewSemantic proximity Read ↗

Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.Semantic proximity Read ↗

Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors.Semantic proximity Read ↗

Tolerance to factor VIII in the era of nonfactor therapies: immunologic perspectives and a systematic review of the literature.Semantic proximity Read ↗

Inhibitors in mild/moderate haemophilia A: an update.Semantic proximity Read ↗

New predictive approaches for ITI treatment.Semantic proximity Read ↗

The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.Semantic proximity Read ↗

The incidence of inhibitors in hemophilia A and the induction of immune tolerance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.